Bristol-Myers Squibb
BMY
BMY
1,733 hedge funds and large institutions have $71.6B invested in Bristol-Myers Squibb in 2017 Q4 according to their latest regulatory filings, with 194 funds opening new positions, 605 increasing their positions, 677 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,733
Holders Change
+94
Holders Change %
+5.74%
% of All Funds
39.36%
Holding in Top 10
45
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-22.41%
% of All Funds
1.02%
New
194
Increased
605
Reduced
677
Closed
82
Calls
$2.02B
Puts
$1.81B
Net Calls
+$209M
Net Calls Change
-$187M
Top Buyers
| 1 |
BlackRock
New York
|
$6.39B |
| 2 |
Citadel Advisors
Miami,
Florida
|
$360M |
| 3 |
Renaissance Technologies
New York
|
$876M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
$670M |
| 5 |
D.E. Shaw & Co
New York
|
$280M |
